# Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis

> **NCT03676933** · PHASE2 · COMPLETED · sponsor: **DS Biopharma** · enrollment: 5 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** DS107E
- **DRUG:** Vehicle
- **DRUG:** Hydrocortisone Butyrate 0.1% Cream

## Key facts

- **NCT ID:** NCT03676933
- **Lead sponsor:** DS Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-04-25
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03676933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03676933, "Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03676933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*